FDA 483 - OneBlood, Inc. - April 18, 2019

An FDA inspection of OneBlood, Inc. in Pensacola, FL, a community blood center, identified a significant issue during a mobile blood drive. The firm failed to provide adequate private space for individuals to complete computer-assisted self-interviews to determine their eligibility as blood donors. This condition could compromise the accuracy and privacy of sensitive donor screening information.